Issue 213

03.09.2021

Europe
USA
Latam & Caribbean
APAC
Africa & Middle East

HIGHLIGHTS 

 

THE PHARMACEUTICAL CANNABIS REPORT: 2ND EDITION – AVAILABLE NOW

The use of cannabinoids in the treatment of medical conditions offers major opportunities and challenges to anyone operating in the space.

Research on the endocannabinoid system is one of the most promising avenues for new therapeutics in medicine at the moment; however, regulations are constantly shifting beneath the feet of operators, and their ability to serve patients depends on their capacity to navigate a changing landscape of governance.

The Pharmaceutical Cannabis Report: 2nd Edition will give you a deeper understanding of the pharmaceutical cannabis market, the potential challenges and opportunities, key trends in the global market, the market authorisation process for pharmaceutical cannabis products, and successful pharmaceutical companies in the cannabis space.

LEARN MORE »

 


 

USDA LAUNCHES NATIONAL SURVEY OF HEMP FARMERS TO INFORM HEMP AND CANNABIS POLICY REFORM

READ MORE »

 

BILL PASSES PANAMA’S NATIONAL ASSEMBLY IN UNANIMOUS VOTE TO REGULATE MEDICAL CANNABIS 

READ MORE »

Europe

USA

UPCOMING EVENT

LEAFLY ANNOUNCED AS HEADLINE SPONSOR FOR BUSINESS OF CANNABIS: NEW YORK 

Leafly, the world’s most trusted destination for discovering and ordering cannabis products, has been confirmed as the headline sponsor for the Business of Cannabis: New York summit on 29 September.

The partnership comes after a busy period for Leafly’s executive team, during which time the Washington-based cannabis technology firm announced its intentions to go public through a SPAC merger with Merida Merger Corp., in a deal worth a reported US$532 million. Leafly CEO Yoko Miyashita has also been confirmed as a speaker at the Business of Cannabis: New York summit.

READ MORE »

CANADA

LATAM & CARIBBEAN

EVENT

 

LET’S PUSH THINGS FORWARD AT CANNABIS EUROPA LONDON

Cannabis Europa London will deliver cutting-edge knowledge from senior government officials, leading scientific experts and some of the most influential businesses in the industry. Navigate the European cannabis market by connecting and collaborating with industry leaders and regulators.

Meet the right people to help expand your business, share insights and innovations, and establish Europe as the leading region for global cannabis. Join major institutions who attend, such as the European Parliament, JP Morgan, Unilever, Heineken, Barclays and the British Government.

 

SECURE YOUR SEAT >>

APAC

  • Australian university to study the effects of cannabis decriminalisation on cannabis users in the Australian Capital Territory.
  • Creso Pharma and Red Light Holland call off proposed merger, to list on the NASDAQ as separate entities.
  • NZ Organic Genetics begins a NZ$4 million crowdfunding round to build an EU GMP certified facility in Auckland.
  • Hempsi lands a CBD oil export contract with a South Korean retailer, supplying 220,000 units per year.
  • Nepal establishes its first hemp research institute, encouraging sustainable industrial and economic growth.

AFRICA & MIDDLE EAST

Read the stories that shape the cannabis industry